Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers
- 25 November 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 18 (4), 334-343
- https://doi.org/10.1038/gt.2010.149
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Critical design criteria for minimal antibiotic‐free plasmid vectors necessary to combine robust RNA Pol II and Pol III‐mediated eukaryotic expression with high bacterial production yieldsThe Journal of Gene Medicine, 2010
- Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoproteinVirology, 2009
- Identification of Protein Cofactors Necessary for Sequence-specific Plasmid DNA Nuclear ImportMolecular Therapy, 2009
- Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection systemVaccine, 2009
- Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear ImportPublished by Elsevier BV ,2009
- Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised HostMolecular Therapy, 2009
- Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream productionBiotechnology Advances, 2009
- Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processesBiotechnology & Bioengineering, 2009
- Electroporation for the Delivery of DNA-based Vaccines and Immunotherapeutics: Current Clinical DevelopmentsMolecular Therapy, 2009
- Age‐dependent impairment of HIF‐1α expression in diabetic mice: Correction with electroporation‐facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cellsJournal of Cellular Physiology, 2008